title: [Relation of C-reactive protein and coronary heart disease. Current knowledges].
abstract: Originally meant as a marker of inflammation in coronary heart disease (CHD), C reactive protein (CRP) is becoming an important tool in the clinical management of CHD patients. Several studies, and in particular the recent JUPITER trial, confirm its feasibility in intermediate risk patients; furthermore, according to last evidence, CRP could be a target for new therapeutic strategies.
authors.affiliation: Istituto di Cardiologia, Dipartimento di Medicina Cardiovascolare, Policlinico Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma.
authors.forename: Gina
authors.initials: G
authors.lastname: Biasillo
authors.forename: Giovanni Luigi
authors.initials: GL
authors.lastname: De Maria
authors.forename: Milena
authors.initials: M
authors.lastname: Leo
authors.forename: Antonella
authors.initials: A
authors.lastname: Stefanelli
authors.forename: Luigi Marzio
authors.initials: LM
authors.lastname: Biasucci
mesh_terms: D002097:C-Reactive Protein / Q000037:antagonists & inhibitors / Q000502:physiology*; D003327:Coronary Disease / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D011379:Prognosis; D018570:Risk Assessment
chemical_list: D002097:C-Reactive Protein